April 24, 2025) - Scott+Scott Attorneys at Law LLP ("Scott+Scott"), a shareholder and consumer rights litigation firm, alerts investors that a securities class action lawsuit has been filed in the ...

Berger Montague PC advises investors that a securities class action lawsuit has been filed against Zynex, Inc. ("Zynex" or the "Company") on behalf of purchasers of Zynex securities between March 13, ...

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive ...

Levi & Korsinsky, LLP notifies investors in Zynex, Inc. ("Zynex, Inc." or the "Company") of a class action securities lawsuit.

Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Zynex To Contact Him Directly To Discuss Their Options ...

NEW YORK, NY / ACCESS Newswire / April 20, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...

PRNewswire/ -- ...

On April 15, 2025, RBC Capital Markets reportedly further reduced its price target for Zynex stock to $5 per share. This marks the second downward revision in as many months and represents a ...

If you purchased or acquired securities in Zynex between March 13, 2023 and March 11, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at ...

SAN FRANCISCO, April 11, 2025 (GLOBE NEWSWIRE) -- Shares of Zynex Inc. (NASDAQ: ZYXI), a medical device manufacturer specializing in nerve stimulation products, are trading down 65% over the past ...